regeneron reports positive results on initial data for covid-19 antibody drug
Published 3 years ago • 2.5K plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
4:17
regeneron reports antibody drug lowers risk of medical visits by 57%
-
1:08
regeneron receives $450 million federal contract for covid-19 antibody drug
-
5:32
regeneron's science chief on starting clinical trials for covid-19 antibody drug
-
2:17
regeneron's antibody drug offers strong protection against covid-19
-
1:26
regeneron to ask fda to expand eua for antibody treatment after positive study results
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
3:53
regeneron president on covid antibody cocktail efficacy and supply chain
-
2:01
regeneron's antibody drug reduces risk of death in some covid patients
-
3:36
jim cramer: don't buy regeneron stock just because trump says its covid-19 antibody cocktail works
-
3:03
intellia, regeneron complete first systemic delivery of crispr in body
-
1:32
president donald trump has received regeneron antibody cocktail after covid-19 diagnosis
-
3:11
regeneron chief scientist explains promising results for covid-19 antibody cocktail
-
2:02
regeneron's antibody drug likely to be in short supply because it's grown in live cells
-
3:30
regeneron reports antibody treatment is less effective against omicron variant
-
3:55
regeneron is much greater than this covid-19 story: analyst
-
3:19
regeneron aims for covid-19 drug trials by early summer
-
2:32
regeneron covid-19 'antibody cocktail' drug enters late-stage trials
-
6:23
regeneron ceo on fda request for expanded eua of covid antibody drug
-
2:55
regeneron ceo on distribution of covid-19 antibody cocktail
-
2:27
regeneron: covid antibody loses potency against omicron
-
1:56
president donald trump's antibodies are likely from antibody drug: regeneron
-
1:59
cnbc's meg tirrell explains regeneron's antibody cocktail